• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病连续体中的胆碱能白质通路。

Cholinergic white matter pathways along the Alzheimer's disease continuum.

机构信息

Department of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.

Department of Biomedical Engineering and Assistive Technology, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic.

出版信息

Brain. 2023 May 2;146(5):2075-2088. doi: 10.1093/brain/awac385.

DOI:10.1093/brain/awac385
PMID:36288546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10151179/
Abstract

Previous studies have shown that the cholinergic nucleus basalis of Meynert and its white matter projections are affected in Alzheimer's disease dementia and mild cognitive impairment. However, it is still unknown whether these alterations can be found in individuals with subjective cognitive decline, and whether they are more pronounced than changes found in conventional brain volumetric measurements. To address these questions, we investigated microstructural alterations of two major cholinergic pathways in individuals along the Alzheimer's disease continuum using an in vivo model of the human cholinergic system based on neuroimaging. We included 402 participants (52 Alzheimer's disease, 66 mild cognitive impairment, 172 subjective cognitive decline and 112 healthy controls) from the Deutsches Zentrum für Neurodegenerative Erkrankungen Longitudinal Cognitive Impairment and Dementia Study. We modelled the cholinergic white matter pathways with an enhanced diffusion neuroimaging pipeline that included probabilistic fibre-tracking methods and prior anatomical knowledge. The integrity of the cholinergic white matter pathways was compared between stages of the Alzheimer's disease continuum, in the whole cohort and in a CSF amyloid-beta stratified subsample. The discriminative power of the integrity of the pathways was compared to the conventional volumetric measures of hippocampus and nucleus basalis of Meynert, using a receiver operating characteristics analysis. A multivariate model was used to investigate the role of these pathways in relation to cognitive performance. We found that the integrity of the cholinergic white matter pathways was significantly reduced in all stages of the Alzheimer's disease continuum, including individuals with subjective cognitive decline. The differences involved posterior cholinergic white matter in the subjective cognitive decline stage and extended to anterior frontal white matter in mild cognitive impairment and Alzheimer's disease dementia stages. Both cholinergic pathways and conventional volumetric measures showed higher predictive power in the more advanced stages of the disease, i.e. mild cognitive impairment and Alzheimer's disease dementia. In contrast, the integrity of cholinergic pathways was more informative in distinguishing subjective cognitive decline from healthy controls, as compared with the volumetric measures. The multivariate model revealed a moderate contribution of the cholinergic white matter pathways but not of volumetric measures towards memory tests in the subjective cognitive decline and mild cognitive impairment stages. In conclusion, we demonstrated that cholinergic white matter pathways are altered already in subjective cognitive decline individuals, preceding the more widespread alterations found in mild cognitive impairment and Alzheimer's disease. The integrity of the cholinergic pathways identified the early stages of Alzheimer's disease better than conventional volumetric measures such as hippocampal volume or volume of cholinergic nucleus basalis of Meynert.

摘要

先前的研究表明,在阿尔茨海默病痴呆症和轻度认知障碍患者中,梅内尔特胆碱能核及其白质投射受到影响。然而,目前尚不清楚这些改变是否可以在有主观认知下降的个体中发现,以及它们是否比在常规脑容积测量中发现的改变更为明显。为了解决这些问题,我们使用基于神经影像学的人类胆碱能系统的体内模型,研究了沿着阿尔茨海默病连续体的两条主要胆碱能通路的微观结构改变。我们从德国神经退行性疾病中心纵向认知障碍和痴呆症研究中纳入了 402 名参与者(52 名阿尔茨海默病患者、66 名轻度认知障碍患者、172 名主观认知下降患者和 112 名健康对照组)。我们使用增强的扩散神经影像学管道对胆碱能白质通路进行建模,该管道包括概率纤维追踪方法和先前的解剖学知识。我们在整个队列和 CSF 淀粉样β分层亚组中比较了阿尔茨海默病连续体各阶段之间、整个队列和 CSF 淀粉样β分层亚组之间胆碱能白质通路的完整性。使用接收器操作特性分析比较了这些通路完整性与海马体和梅内尔特胆碱能核的常规容积测量的区分能力。使用多变量模型研究了这些通路与认知表现的关系。我们发现,在阿尔茨海默病连续体的所有阶段,包括有主观认知下降的个体,胆碱能白质通路的完整性都显著降低。这些差异涉及主观认知下降阶段的后部胆碱能白质,在轻度认知障碍和阿尔茨海默病痴呆阶段扩展到额前白质。胆碱能通路和常规容积测量在疾病的更晚期(即轻度认知障碍和阿尔茨海默病痴呆)均显示出更高的预测能力。相比之下,与容积测量相比,胆碱能通路的完整性在区分主观认知下降与健康对照组方面更具信息量。多变量模型显示,在主观认知下降和轻度认知障碍阶段,胆碱能白质通路对记忆测试的中等贡献,但容积测量则不然。总之,我们证明了胆碱能白质通路在主观认知下降个体中已经发生改变,早于轻度认知障碍和阿尔茨海默病中发现的更广泛的改变。与海马体体积或梅内尔特胆碱能核体积等常规容积测量相比,胆碱能通路的完整性能更好地识别阿尔茨海默病的早期阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/1cedfc800ff3/awac385f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/4d0f2b92e057/awac385f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/04bea72c22fa/awac385f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/75f1989be476/awac385f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/05b07706366a/awac385f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/1cedfc800ff3/awac385f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/4d0f2b92e057/awac385f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/04bea72c22fa/awac385f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/75f1989be476/awac385f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/05b07706366a/awac385f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da95/10151179/1cedfc800ff3/awac385f5.jpg

相似文献

1
Cholinergic white matter pathways along the Alzheimer's disease continuum.阿尔茨海默病连续体中的胆碱能白质通路。
Brain. 2023 May 2;146(5):2075-2088. doi: 10.1093/brain/awac385.
2
Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.路易体痴呆和阿尔茨海默病的胆碱能白质通路。
Brain. 2022 Jun 3;145(5):1773-1784. doi: 10.1093/brain/awab372.
3
Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.客观轻微认知障碍个体的胆碱能白质通路和梅内尔特基底核的退化。
Neurobiol Aging. 2023 Dec;132:198-208. doi: 10.1016/j.neurobiolaging.2023.09.011. Epub 2023 Sep 25.
4
Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.胆碱能白质通路对正常衰老过程中的注意力和记忆力的贡献比脑血管健康和梅内特基底核更强。
Neuroimage. 2020 May 1;211:116607. doi: 10.1016/j.neuroimage.2020.116607. Epub 2020 Feb 6.
5
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.结构(功能)连接与阿尔茨海默病中的胆碱能细胞密度有关。
Brain. 2022 Aug 27;145(8):2869-2881. doi: 10.1093/brain/awac093.
6
Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍患者的纤维特异性白质减少。
Brain. 2018 Mar 1;141(3):888-902. doi: 10.1093/brain/awx355.
7
White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.阿尔茨海默病痴呆前阶段的脑白质完整性破坏:从主观记忆损害到遗忘型轻度认知障碍。
Eur J Neurol. 2019 May;26(5):800-807. doi: 10.1111/ene.13892. Epub 2019 Jan 23.
8
Microstructural brain changes track cognitive decline in mild cognitive impairment.脑微观结构变化可追踪轻度认知障碍的认知能力下降。
Neuroimage Clin. 2018;20:883-891. doi: 10.1016/j.nicl.2018.09.027. Epub 2018 Sep 26.
9
Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?基底核内 Meynert 核的线性测量是否适合作为轻度认知障碍和阿尔茨海默病的诊断生物标志物?
AJNR Am J Neuroradiol. 2019 Dec;40(12):2039-2044. doi: 10.3174/ajnr.A6313. Epub 2019 Nov 14.
10
Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer's continuum.主观认知衰退:在阿尔茨海默病连续体中与神经退行性变的相反联系。
Brain Commun. 2021 Sep 1;3(3):fcab199. doi: 10.1093/braincomms/fcab199. eCollection 2021.

引用本文的文献

1
Longitudinal impact of cholinesterase inhibitors on cholinergic white matter integrity in mild cognitive impairment: A diffusion MRI study.胆碱酯酶抑制剂对轻度认知障碍患者胆碱能白质完整性的纵向影响:一项扩散磁共振成像研究
J Alzheimers Dis Rep. 2025 Aug 28;9:25424823251374681. doi: 10.1177/25424823251374681. eCollection 2025 Jan-Dec.
2
Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum.路易体连续体中脑血管疾病与胆碱能白质通路之间的区域关联。
NPJ Parkinsons Dis. 2025 Aug 21;11(1):250. doi: 10.1038/s41531-025-01118-5.
3
Associations between digital speech features of automated cognitive tasks and trajectories of brain atrophy and cognitive decline in early Alzheimer's disease.

本文引用的文献

1
Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.认知正常个体中脑血管和阿尔茨海默病生物标志物与胆碱能白质退变的关联。
Neurology. 2022 Oct 11;99(15):e1619-e1629. doi: 10.1212/WNL.0000000000200930. Epub 2022 Aug 2.
2
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.结构(功能)连接与阿尔茨海默病中的胆碱能细胞密度有关。
Brain. 2022 Aug 27;145(8):2869-2881. doi: 10.1093/brain/awac093.
3
Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
早期阿尔茨海默病中自动化认知任务的数字语音特征与脑萎缩轨迹及认知衰退之间的关联。
J Alzheimers Dis. 2025 Sep;107(1):154-169. doi: 10.1177/13872877251359967. Epub 2025 Jul 20.
4
Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum.沿路易体连续体的脑血管共同病理学和胆碱能白质通路。
Brain Commun. 2025 May 6;7(3):fcaf173. doi: 10.1093/braincomms/fcaf173. eCollection 2025.
5
Neuroprotective, and memory enhancement effects of Salvia aristata and its phenolic constituents: an in vitro, and in vivo study.鼠尾草及其酚类成分的神经保护和记忆增强作用:一项体外和体内研究。
BMC Complement Med Ther. 2025 May 17;25(1):181. doi: 10.1186/s12906-025-04902-1.
6
Cognitive impairment and vulnerability of cholinergic brain network in the Alzheimer's continuum: free-water imaging based on diffusion tensor imaging.阿尔茨海默病连续体中胆碱能脑网络的认知障碍与易损性:基于扩散张量成像的自由水成像
Front Neurosci. 2025 Apr 30;19:1587702. doi: 10.3389/fnins.2025.1587702. eCollection 2025.
7
Brain cholinergic terminal density utilizing [F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance.利用[F] - 氟乙氧基苯甲胍PET对唐氏综合征成人患者脑胆碱能终末密度的研究:与淀粉样蛋白PET及认知表现的关系
Alzheimers Dement. 2025 Apr;21(4):e70134. doi: 10.1002/alz.70134.
8
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [F]-fluoroethoxybenzovesamicol positron emission tomography imaging.与通过[F]-氟乙氧基苯甲戊胺正电子发射断层扫描成像测量的神经典型对照相比,唐氏综合征成人胆碱能终末密度的差异。
Neurobiol Aging. 2025 Apr;148:50-60. doi: 10.1016/j.neurobiolaging.2025.01.008. Epub 2025 Jan 30.
9
Structural and Functional Projections of the Nucleus Basalis of Meynert and Their Changes After Cognitive Training in Individuals With Mild Cognitive Impairment.梅纳特基底核的结构和功能投射及其在轻度认知障碍个体认知训练后的变化。
CNS Neurosci Ther. 2024 Dec;30(12):e70194. doi: 10.1111/cns.70194.
10
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [F]-Fluoroethoxybenzovesamicol Positron Emission Tomography Imaging.使用[F] -氟乙氧基苯甲酰甲基胆碱正电子发射断层扫描成像评估唐氏综合征成年患者胆碱能系统的年龄相关变化。
medRxiv. 2024 Nov 1:2024.10.28.24316136. doi: 10.1101/2024.10.28.24316136.
脑脊液、血浆和神经退行性病变影像学标志物与主观认知下降患者临床进展的相关性。
Neurology. 2022 Mar 29;98(13):e1315-e1326. doi: 10.1212/WNL.0000000000200035. Epub 2022 Feb 2.
4
Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.路易体痴呆和阿尔茨海默病的胆碱能白质通路。
Brain. 2022 Jun 3;145(5):1773-1784. doi: 10.1093/brain/awab372.
5
Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume.淀粉样蛋白-β阳性、有主观认知下降的个体存在脑脊液神经丝轻链水平升高,与海马体积较低有关。
Neurobiol Aging. 2021 Aug;104:24-31. doi: 10.1016/j.neurobiolaging.2021.02.026. Epub 2021 Mar 6.
6
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias.脑脊液 N-224tau 有助于区分阿尔茨海默病与主观认知下降和其他痴呆症。
Alzheimers Res Ther. 2021 Feb 8;13(1):38. doi: 10.1186/s13195-020-00756-6.
7
Posterior Cingulate Cortex Network Predicts Alzheimer's Disease Progression.后扣带回皮质网络可预测阿尔茨海默病的进展。
Front Aging Neurosci. 2020 Dec 15;12:608667. doi: 10.3389/fnagi.2020.608667. eCollection 2020.
8
Minor neuropsychological deficits in patients with subjective cognitive decline.主观认知下降患者的轻度神经心理学缺陷。
Neurology. 2020 Sep 1;95(9):e1134-e1143. doi: 10.1212/WNL.0000000000010142. Epub 2020 Jul 7.
9
Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.基底前脑体积可靠地预测阿尔茨海默病退行性变的皮质扩散。
Brain. 2020 Mar 1;143(3):993-1009. doi: 10.1093/brain/awaa012.
10
Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.胆碱能白质通路对正常衰老过程中的注意力和记忆力的贡献比脑血管健康和梅内特基底核更强。
Neuroimage. 2020 May 1;211:116607. doi: 10.1016/j.neuroimage.2020.116607. Epub 2020 Feb 6.